Select Biosciences, Inc. Stem Cells in Drug Discovery & Toxicity Screening 2017 is held concurrently with the Select Biosciences, Inc. Third Annual Organ-on-a-Chip World Congress 2017 focuses on an important and expanding field wherein cells are being assembled using Microfluidics and Lab-on-a-Chip technologies in a functionally-relevant manner.  These clusters of "assembled cells" have functional significance and can mimic in vivo organ structure.

Liver cells assembled on-board chips in a physiologically-relevant architecture using microfluidics can, for instance, be utilized for toxicity screening and the ability to assemble organ fragments ex vivo can provide an exquisite means to reconstruct biological processes (both physiological and pathological) "in a dish" or "on a chip."  A number of chips such Lung-on-a-Chip, Brain-on-a-Chip, Gut-on-a-Chip, Marrow-on-a-Chip, Bone-on-a-Chip, Nerve-on-a-Chip amongst others have been built and will be presented and explored at this conference. We will also focus on "disease-on-a-chip", cancer-on-a-chip, immune system-on-a-chip and toxicity screening-on-a-chip.

The Three Conference Tracks are Co-Located and Concurrent and Delegates can Participate, Mix-and-Match Presentations and Network Extensively with their Colleagues from all 3 Conference Tracks.

Co-Located, Concurrent Conference Tracks:

• Organ-on-a-Chip World Congress 2017
• 3D-Culture 2017
• Stem Cells in Drug Discovery & Toxicity Screening 2017

All the Key Opinion Leaders from around the World are Participating at this Conference allowing Maximal Information Exchange and Unparalleled Networking Opportunities.